Physician Ownership and the Missing Stock-Transfer Agreements
The single most important unresolved structural document is the one that says how a physician owner can be replaced.
Orientation
This page is about a negative result, and it states it plainly. A final targeted search of the public litigation, bankruptcy, county-contract, labour and corporate-disclosure record did not locate the CFMG stock ledger, a CFMG-specific stock-transfer agreement, a shareholder roster, a buy-sell agreement, a proxy, an option, a succession agreement, or any Company Designee appointment.
That matters because of where the search has already been. The shareholder question should now be treated as a document-production gap rather than a question more searching will answer.
Five statuses that must stay separate
The governing rule on this page: never infer stock ownership from title.
| Status | What it proves |
|---|---|
| Officer | Authority to act for the corporation in a defined role |
| Director | A seat in corporate governance |
| Shareholder | Equity — and the ability to be removed from it |
| Professional decision-maker | Participation in clinical or professional determinations |
| Enterprise physician executive | A role in the management organisation |
A person may hold several. Documentation of one is not evidence of another. CFMG’s current officers — Bazzel, Medrano and Kennedy — are established as officers and directors. Shareholder status is not established for any of them, and this investigation does not assert it.
government recordopen
What the record does establish
- Wellpath’s March 2026 California announcement describes CFMG as a professional corporation “owned by licensed physicians” and affiliated with Wellpath’s management-services organisation. It names no physician and states no percentage. This is established as Wellpath’s current representation, which is a different proposition from established as fact.
- The 2019 assignment expressly references CFMG-related stock-transfer restriction instruments.
- The bankruptcy motion describes the enterprise-wide function of stock transfer agreements between debtors and certain physician owners: restricting transfers of professional-corporation shares, facilitating succession, preserving professional qualification, and maintaining continuity of administrative services. The debtors stated they held authority under those agreements to ensure the professional corporations remained licensed and qualified. See: The Eighteen
bankruptcy record
The enterprise description cannot be imported term-for-term into CFMG. The motion says “certain PC Physicians.” It does not say every professional corporation used identical provisions. The CFMG instrument itself is still missing, and the generic description does not supply its terms.
The Rule 7.1 anomaly
The final sweep produced something more consequential than another ownership inference: a direct conflict inside the defendants’ own corporate disclosures.
| Record | Date | What it says |
|---|---|---|
| Beckner | October 2023 | Wellpath LLC’s Certificate of Interested Entities identifies California Forensic Medical Group, Inc. as a “Corporate Parent” of Wellpath LLC |
| Sand | January 2024 | Same formulation |
| Avila | November 2024 | Same formulation |
| Strieter | July 2024 | Wellpath identifies CFMG merely as an “Other Affiliate” |
| Venegas | March 2026 | CFMG reciprocally identifies Wellpath LLC as an “Other Affiliate” |
| Bankruptcy organisational chart | 2024–25 | Places Wellpath LLC, Wellpath Management, Inc. and Wellpath CFMG, Inc. within the Wellpath Holdings ownership structure. The California professional corporation is not depicted as the equity parent of Wellpath LLC. |
| Non-California disclosures | — | Wellpath LLC identifies Wellpath Group Holdings, LLC and Jessamine Healthcare, Inc. as its corporate parents |
docket recordbankruptcy record
Unresolved contradiction — is CFMG the corporate parent of Wellpath LLC?
Taken literally, three Northern District filings would place CFMG above Wellpath LLC in an equity hierarchy. That is irreconcilable with the debtor’s own bankruptcy organisational chart and with Wellpath LLC’s corporate-parent disclosures outside California.
The anomaly cannot be dismissed as plaintiff confusion. The entries were filed by defence counsel. But they also cannot override the debtor’s formal ownership chart without reconciliation.
The evidence rule this produces: Northern District docket metadata describing CFMG as Wellpath LLC’s “Corporate Parent” should not be treated as a reliable equity-ownership finding unless the actual filed disclosure document — and its intended use of that term — is obtained and reconciled against the bankruptcy organisational chart and the other Rule 7.1 filings.
Resolving documents: the filed Certificates of Interested Entities in Beckner, Sand and Avila — the forms themselves, not the docket metadata — read against the bankruptcy organisational chart.
An entity-precision note. Wellpath CFMG, Inc., formerly known as CFMG Holdings Corp., is a separate debtor-side entity. It is not California Forensic Medical Group, Inc., the professional corporation. The names are close enough that conflating them would invert the whole analysis. See: The Three-Entity Problem
The four evidence levels
| Proposition | Status |
|---|---|
| CFMG is a professional corporation | Established |
| Wellpath publicly represents CFMG as physician-owned | Established as Wellpath’s current representation |
| CFMG-related stock-transfer restrictions existed | Strongly established from the 2019 assignment |
| Wellpath used stock transfer agreements across its professional-corporation network | Established as debtor representation |
| Exact CFMG shareholder names | Not established |
| Exact CFMG share percentages | Not established |
| CFMG physician-owner succession mechanism | Not established |
| Wellpath right to approve a CFMG successor owner | Not established |
| Wellpath right to force transfer of CFMG stock | Not established |
| Wellpath voting or proxy power over CFMG shares | Not established |
| CFMG direct equity ownership of Wellpath LLC | Conflicting procedural metadata; not established |
| Wellpath LLC direct equity ownership of CFMG | Not established |
The succession test
The question this page exists to pose is not who signed a contract. It is:
Could a CFMG physician refuse the manager without risking ownership or office?
Answering it requires four things: who owned shares, in what proportions, by year; who appointed each succeeding officer; who controlled transfer; and whether the manager held rights over the shares.
What this page establishes
That stock-transfer restrictions existed in the CFMG relationship; that across the network such instruments served the continuity of the manager’s administrative services; and that the defendants’ own corporate disclosures describe the CFMG–Wellpath LLC relationship in at least three mutually inconsistent ways within thirty months.
What this page does not establish
Who owns CFMG. What its stock-transfer agreement says. Whether any nonprofessional entity holds nomination, consent, option, proxy or enforcement rights over CFMG shares. No inference in any direction is available from the absence of these documents.
Why this is the decisive document
The missing succession mechanism determines how credible CFMG’s formal professional veto is when its physician leadership and the management organisation disagree. A reservation of professional authority held by an owner who can be replaced at the counterparty’s election is a different instrument from the same reservation held by an owner who cannot.
Everything on The Right to Leave turns on which of those two the record describes.
Documents still missing
- CFMG stock ledger and shareholder list by year
- CFMG stock-transfer restriction agreement — the operative text
- CFMG articles, bylaws, shareholder agreement and any buy-sell agreement
- Proxies, options and succession instruments
- Company Designee appointment records
- The filed Certificates of Interested Entities in Beckner, Sand and Avila
- Wellpath’s bankruptcy organisational chart at native resolution
- Herr-to-Bazzel succession records, 2021–22 minute books
No such documents have been located in the public record reviewed for this project. That is a statement about this review, not about whether they exist.
Why the 2026 enforcement record makes this the decisive document
In Art Center Holdings v. WCE CA Art the Attorney General argues that when an unlicensed management company holds the contractual right to replace the physician owner with a physician of its choosing, it can effectively own and control the practice — and that when the physician owner cannot replace the management company without risking loss of the practice, the management company can hold undue control. The brief examines exactly the instruments this page is looking for: continuity agreements, assignable options and stock-transfer arrangements. The Carbon Health complaint describes succession and option provisions and security interests in physician shares of the same kind.
Neither is a finding about CFMG. Art Center is an amicus position in a pending appeal, opposed in part by the California Medical Association’s call for a contextual analysis; Carbon Health is a complaint with an announced settlement that the Attorney General describes as subject to court approval. But they convert the missing CFMG instrument from a gap in corporate history into the single document most likely to answer the state’s own control test: who controls CFMG shareholder succession, and can the physician owner replace Wellpath without losing or disabling CFMG?
See the owner-replacement row of the California control-indicator matrix. Added 25 September 2026.
Related litigation
Beckner v. County of Santa Cruz · Sand · Avila · Strieter · Venegas · Madrid v. County of Tulare · Vizgaudis-Gomez
Principal public sources
- Wellpath Chapter 11 first-day professional-corporation motion (Dkt. 15) — stock transfer agreements
- Wellpath Holdings, Inc., Case No. 24-90533 — ownership chart and confirmed Plan
- Beckner v. County of Santa Cruz — Certificate of Interested Entities, October 2023
- Sand (January 2024), Avila (November 2024), Strieter (July 2024) and Venegas (March 2026) — corporate disclosure docket entries
- Wellpath announcement, March 2026 — Local Government–California division and CFMG description
- 1 January 2019 assignment of management-services agreement — referencing stock-transfer restriction agreements